SEC 13F Intelligence

Duquesne Family Office LLC / NRIX

Duquesne Family Office LLC’s Nurix Therapeutics Inc Position

Does Duquesne Family Office LLC own Nurix Therapeutics Inc (NRIX)? Not currently — the last reported position was 44.2K shares worth $993,000 in Q3 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$993,000
Q3 2024
Shares
44.2K
% of Portfolio
+0.03%
Quarters Held
3
position exited

Position History NRIX

Reported value by quarter
Q1 ’24: $650,000Q1 ’24Q2 ’24: $922,000Q2 ’24Q3 ’24: $993,000Q3 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q3 202444.2K$993,000+0.03%
Q2 202444.2K$922,000+0.03%
Q1 202444.2K$650,000+0.01%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Duquesne Family Office LLC’s full portfolio or all institutional holders of NRIX.